BU09059

From WikiMD's WELLNESSPEDIA

BU09059 is a drug that is used in scientific research. It is a selective antagonist for the mu opioid receptor. BU09059 is notable for its ability to distinguish between the different subtypes of the mu opioid receptor, which is a unique property among opioid antagonists. This makes it a valuable tool in the study of the opioid system.

Pharmacology[edit]

BU09059 is a opioid antagonist, meaning it blocks the action of opioids at their receptor sites. It is selective for the mu opioid receptor, one of the three main types of opioid receptors in the body. This receptor is primarily responsible for the pain-relieving effects of opioids.

The unique property of BU09059 is its ability to distinguish between the different subtypes of the mu opioid receptor. This is important because different subtypes can have different effects in the body, and being able to selectively block one subtype over another can have significant implications for the development of new drugs.

Uses[edit]

BU09059 is primarily used in scientific research. Its ability to selectively block certain subtypes of the mu opioid receptor makes it a valuable tool in the study of the opioid system. This can help researchers better understand how opioids work in the body, and potentially lead to the development of new drugs that can provide pain relief without the risk of addiction.

See also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.